TABLE 1.
2-Drug | 3-Drug | Total | 2 vs. 3 | Subgroup | |
---|---|---|---|---|---|
Overall | 92% | 82% | 87% | P < .02 | |
1st Cadaveric | 90% | 87% | 88% | NS | |
1st Transplant | 90% | 87% | 89% | NS | NS |
Retransplantation | 97% | 72% | 84% | P < .02 | |
Cadaveric | 92% | 82% | 87% | P < .03 | NS |
Living-donor | 94% | 88% | 92% | NS | |
PRA <40% | 91% | 84% | 87% | NS | NS |
PRA >40% | 100% | 77% | 86% | P < .04 | |
Adult kidneys | 93% | 83% | 88% | P < .02 | NS |
En bloc | 80% | 79% | 79% | NS | |
No ATN | 100% | 88% | 93% | P < .001 | P < .0001 |
ATN | 81% | 71% | 77% | NS | |
Rejection | 91% | 76% | 85% | P < .03 | NS |
No rejection | 94% | 87% | 90% | NS | |
Donors >60 years | 77% | 80% | 78% | NS | NS |
Donors <60 years | 94% | 83% | 88% | P < .02 | |
Black | 92% | 87% | 89% | NS | NS |
Nonblack | 92% | 82% | 87% | P < .02 | |
Recipients <60 years | 93% | 83% | 88% | P < .02 | NS |
Recipients >60 years | 82% | 82% | 82% | NS |